The androgenic profile of women with non-insulin-dependent diabetes mellitus
dc.contributor.author | Tok, EC | |
dc.contributor.author | Ertunc, D | |
dc.contributor.author | Evruke, C | |
dc.contributor.author | Dilek, S | |
dc.date.accessioned | 2024-09-18T21:07:59Z | |
dc.date.available | 2024-09-18T21:07:59Z | |
dc.date.issued | 2004 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: To evaluate the androgenic profile of women with non-insulin-dependent diabetes mellitus. STUDY DESIGN: This case-control study evaluated the clinical, hormonal and ultrasonographic characteristics of women of reproductive age with non-insulin-dependent diabetes mellitus and compared them with those of age- and weight-matched controls. Radioimmunoassays were used for total testosterone, estradiol, dehydroepiandrosterone sulfate (DHEAS) and androstenedione. Sex hormone-binding globulin (SHBG), luteinizing hormone (LH) and follicle stimulating hormone (FSH) were analyzed by fluoroimmunoassays. Ovarian appearance and volume were assessed by transvaginal or transabdominal ultrasonography. RESULTS: The prevalence of polycystic ovary syndrome was higher in diabetic patients than in the general population as reported earlier. Hirsutism was also more prevalent in diabetic patients (p < 0.05). The serum levels of FSH, LH, estradiol, total testosterone, androstenedione and DHEAS were significantly higher in diabetic patients than in the control group (p < 0.05). In contrast, the levels of SHBG were lower in diabetic patients (p < 0.05). The rates of ultrasonographically apparent polycystic ovaries and greater ovarian volumes were also higher in diabetic patients (p < 0.05). CONCLUSION: Women with non-insulin-dependent diabetes mellitus seem to have biochemical and clinical hyperandrogenism when compared with nondiabetic controls. | en_US |
dc.identifier.endpage | 752 | en_US |
dc.identifier.issn | 0024-7758 | |
dc.identifier.issn | 1943-3565 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 15493567 | en_US |
dc.identifier.startpage | 746 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/14067 | |
dc.identifier.volume | 49 | en_US |
dc.identifier.wos | WOS:000224110300010 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sci Printers & Publ Inc | en_US |
dc.relation.ispartof | Journal of Reproductive Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Polycystic-Ovary-Syndrome | en_US |
dc.subject | Adrenal Steroidogenesis | en_US |
dc.subject | Risk-Factors | en_US |
dc.subject | Young Women | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Resistance | en_US |
dc.subject | Hyperandrogenism | en_US |
dc.subject | Dysregulation | en_US |
dc.subject | Secretion | en_US |
dc.subject | Hyperinsulinemia | en_US |
dc.title | The androgenic profile of women with non-insulin-dependent diabetes mellitus | en_US |
dc.type | Article | en_US |